Corynebacterium parvum: Preliminary Report of a Phase I Clinical and Immunological Study in Cancer Patients
- 1 January 1975
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- CHEMOIMMUNOTHERAPY OF ADULT ACUTE LEUKÆMIA PROLONGATION OF REMISSION IN MYELOBLASTIC LEUKÆMIA WITH B.C.G.The Lancet, 1974
- Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. Granulosum and C. ParvumInternational Journal of Cancer, 1974
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- LYMPHOCYTE CYTOTOXICITY IN BLADDER CANCER NO REQUIREMENT FOR THYMUS-DERIVED EFFECTOR CELLS ?The Lancet, 1973
- Biological effects of the adjuvant Corynebacterium parvum: I. Inhibition of PHA, mixed lymphocyte and GVH reactivityCellular Immunology, 1972
- Methotrexate plus bacillus Calmette-Guérin (BCG) and isoniazid in the treatment of cancer of the head and neckThe American Journal of Surgery, 1972
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine FibrosarcomasBMJ, 1970
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- Inhibition of Tumour Growth by Administration of Killed Corynebacterium parvumNature, 1966